|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
198,664,000 |
Market
Cap: |
N/A |
Last
Volume: |
1,335,128 |
Avg
Vol: |
605,887 |
52
Week Range: |
$14.24 - $14.24 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rosen Craig A |
Pres., Research & Development |
|
2004-05-03 |
4 |
OE |
$6.88 |
$34,400 |
D/D |
5,000 |
346,429 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-04-01 |
4 |
AS |
$12.48 |
$62,400 |
D/D |
(5,000) |
341,429 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-04-01 |
4 |
OE |
$4.38 |
$27,270 |
D/D |
5,000 |
346,429 |
|
- |
|
Lawlor Augustine |
Director |
|
2004-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,311 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-03-01 |
4 |
AS |
$12.70 |
$63,500 |
D/D |
(5,000) |
341,429 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-03-01 |
4 |
OE |
$4.38 |
$21,900 |
D/D |
5,000 |
346,429 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1) |
0 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
S |
$13.24 |
$9,006 |
I/I |
(677) |
1 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1 |
2,811,548 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
S |
$12.91 |
$98,094 |
I/I |
(7,548) |
678 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
S |
$12.80 |
$74,294 |
I/I |
(5,774) |
8,226 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
S |
$13.14 |
$469,478 |
D/D |
(35,520) |
2,811,547 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-13 |
4 |
S |
$12.80 |
$2,484,890 |
D/D |
(192,481) |
2,847,067 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
S |
$13.42 |
$165,528 |
I/I |
(12,259) |
14,001 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
S |
$13.38 |
$164,237 |
I/I |
(12,258) |
26,260 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
3,039,547 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
S |
$13.38 |
$3,242,672 |
D/D |
(241,083) |
3,049,547 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
S |
$13.00 |
$312,284 |
I/I |
(23,482) |
38,518 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4 |
S |
$13.00 |
$3,070,948 |
D/D |
(230,918) |
3,290,630 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4/A |
S |
$13.42 |
$165,528 |
I/I |
(12,259) |
14,000 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4/A |
D |
$0.00 |
$0 |
I/I |
(1) |
26,259 |
|
- |
|
Haseltine William A |
Chairman & CEO |
|
2004-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
1 |
3,039,548 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-02-02 |
4 |
AS |
$13.96 |
$69,800 |
D/D |
(5,000) |
341,429 |
|
- |
|
Rosen Craig A |
Pres., Research & Development |
|
2004-02-02 |
4 |
OE |
$4.38 |
$21,900 |
D/D |
5,000 |
346,429 |
|
- |
|
388 Records found
|
|
Page 15 of 16 |
|
|